A citation-based method for searching scientific literature


List of co-cited articles
273 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
45

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.
Cornelis Bisschop, Arja Ter Elst, Lisette J Bosman, Inge Platteel, Mathilde Jalving, Anke van den Berg, Arjan Diepstra, Bettien van Hemel, Gilles F H Diercks, Geke A P Hospers,[...]. Melanoma Res 2018
31
32

Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues.
Ana-Iris Schiefer, Laura Parlow, Lisa Gabler, Ildiko Mesteri, Oskar Koperek, Andreas von Deimling, Berthold Streubel, Matthias Preusser, Annika Lehmann, Udo Kellner,[...]. J Mol Diagn 2016
25
36

Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Linea Melchior, Morten Grauslund, Beatriz Bellosillo, Clara Montagut, Erica Torres, Ester Moragón, Isabel Micalessi, Johan Frans, Veerle Noten, Claire Bourgain,[...]. Exp Mol Pathol 2015
35
25

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
22

BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Filip Janku, Bart Claes, Helen J Huang, Gerald S Falchook, Benoit Devogelaere, Mark Kockx, Isabelle Vanden Bempt, Martin Reijans, Aung Naing, Siqing Fu,[...]. Oncotarget 2015
38
22


Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
Jérôme Solassol, Julie Vendrell, Bruno Märkl, Christian Haas, Beatriz Bellosillo, Clara Montagut, Matthew Smith, Brendan O'Sullivan, Nicky D'Haene, Marie Le Mercier,[...]. PLoS One 2016
31
22

BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
Filip Janku, Helen J Huang, Bart Claes, Gerald S Falchook, Siqing Fu, David Hong, Nishma M Ramzanali, Giovanni Nitti, Goran Cabrilo, Apostolia M Tsimberidou,[...]. Mol Cancer Ther 2016
62
22

Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue.
Louise Johnston, Michael Power, Philip Sloan, Anna Long, Angela Silmon, Ben Chaffey, Andrea Jane Lisgo, Liam Little, Ellen Vercauteren, Torben Steiniche,[...]. J Clin Pathol 2018
19
36

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
Axel Hauschild, Jean-Jacques Grob, Lev V Demidov, Thomas Jouary, Ralf Gutzmer, Michael Millward, Piotr Rutkowski, Christian U Blank, Wilson H Miller, Eckhart Kaempgen,[...]. Lancet 2012
19

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
Georgina V Long, Alexander M Menzies, Adnan M Nagrial, Lauren E Haydu, Anne L Hamilton, Graham J Mann, T Michael Hughes, John F Thompson, Richard A Scolyer, Richard F Kefford. J Clin Oncol 2011
765
19

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
Paul T C Wan, Mathew J Garnett, S Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, C Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford,[...]. Cell 2004
19

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
Georgina V Long, James S Wilmott, David Capper, Matthias Preusser, Yuxiao E Zhang, John F Thompson, Richard F Kefford, Andreas von Deimling, Richard A Scolyer. Am J Surg Pathol 2013
230
19

Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.
Alexander M Menzies, Lauren E Haydu, Lydia Visintin, Matteo S Carlino, Julie R Howle, John F Thompson, Richard F Kefford, Richard A Scolyer, Georgina V Long. Clin Cancer Res 2012
318
19

A landscape of driver mutations in melanoma.
Eran Hodis, Ian R Watson, Gregory V Kryukov, Stefan T Arold, Marcin Imielinski, Jean-Philippe Theurillat, Elizabeth Nickerson, Daniel Auclair, Liren Li, Chelsea Place,[...]. Cell 2012
19

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.
Teofila Seremet, Simon Planken, Max Schreuer, Yanina Jansen, Mélanie Delaunoy, Hakim El Housni, Danielle Lienard, Véronique Del Marmol, Pierre Heimann, Bart Neyns. Melanoma Res 2018
15
40

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.
Marius Ilie, Catherine Butori, Sandra Lassalle, Simon Heeke, Nicolas Piton, Jean-Christophe Sabourin, Virginie Tanga, Kevin Washetine, Elodie Long-Mira, Priscilla Maitre,[...]. Oncotarget 2017
39
19

Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma.
Fanny Barel, Briac Guibourg, Laetitia Lambros, Glen Le Flahec, Pascale Marcorelles, Arnaud Uguen. Acta Derm Venereol 2018
14
42

EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.
Caterina De Luca, Gianluca Gragnano, Pasquale Pisapia, Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone. J Clin Pathol 2017
40
19


Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.
Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Gregory T MacLennan, Rodolfo Montironi. Mod Pathol 2018
211
19

BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
Maria Colombino, Mariaelena Capone, Amelia Lissia, Antonio Cossu, Corrado Rubino, Vincenzo De Giorgi, Daniela Massi, Ester Fonsatti, Stefania Staibano, Oscar Nappi,[...]. J Clin Oncol 2012
349
16

Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.
Emeline Colomba, Zofia Hélias-Rodzewicz, Andreas Von Deimling, Cristi Marin, Nathalie Terrones, Dominique Pechaud, Sylvie Surel, Jean-François Côté, Frédérique Peschaud, David Capper,[...]. J Mol Diagn 2013
130
16

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
Pierre-Jean Lamy, Florence Castan, Nicolas Lozano, Cécile Montélion, Patricia Audran, Frédéric Bibeau, Sylvie Roques, Frédéric Montels, Anne-Claire Laberenne. J Mol Diagn 2015
30
16

Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
Christine Weyn, Sofie Van Raemdonck, Robina Dendooven, Vincent Maes, Karen Zwaenepoel, Suzan Lambin, Patrick Pauwels. BMC Cancer 2017
16
31

Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.
Laetitia Lambros, Charline Caumont, Briac Guibourg, Fanny Barel, Isabelle Quintin-Roué, Pascale Marcorelles, Jean-Philippe Merlio, Arnaud Uguen. J Clin Pathol 2017
32
16


ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
E Van Cutsem, A Cervantes, R Adam, A Sobrero, J H Van Krieken, D Aderka, E Aranda Aguilar, A Bardelli, A Benson, G Bodoky,[...]. Ann Oncol 2016
16

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.
Astrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, Valérie Boige, Bruno Landi, Jean-François Emile, Jean-François Côté, Gorana Tomasic, Christophe Penna, Michel Ducreux,[...]. Cancer Res 2006
12

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.
Paolo A Ascierto, Grant A McArthur, Brigitte Dréno, Victoria Atkinson, Gabrielle Liszkay, Anna Maria Di Giacomo, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas,[...]. Lancet Oncol 2016
586
12

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry.
William Bruno, Claudia Martinuzzi, Virginia Andreotti, Lorenza Pastorino, Francesco Spagnolo, Bruna Dalmasso, Francesco Cabiddu, Marina Gualco, Alberto Ballestrero, Giovanna Bianchi-Scarrà,[...]. Oncotarget 2017
25
16

Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma.
Claire Franczak, Julia Salleron, Cindy Dubois, Pierre Filhine-Trésarrieu, Agnès Leroux, Jean-Louis Merlin, Alexandre Harlé. Mol Diagn Ther 2017
8
50

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.
James Larkin, Paolo A Ascierto, Brigitte Dréno, Victoria Atkinson, Gabriella Liszkay, Michele Maio, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas,[...]. N Engl J Med 2014
12


Distinct sets of genetic alterations in melanoma.
John A Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N Patel, Klaus J Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E LeBoit,[...]. N Engl J Med 2005
12

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
Jeffrey A Sosman, Kevin B Kim, Lynn Schuchter, Rene Gonzalez, Anna C Pavlick, Jeffrey S Weber, Grant A McArthur, Thomas E Hutson, Stergios J Moschos, Keith T Flaherty,[...]. N Engl J Med 2012
12

Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays.
Kevin Qu, Qiulu Pan, Xi Zhang, Luis Rodriguez, Ke Zhang, Hairong Li, Albert Ho, Heather Sanders, Anthony Sferruzza, Shih-Min Cheng,[...]. J Mol Diagn 2013
41
12

EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
Vincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, Antoinette Lemoine, Benjamin Besse, Olaf Mercier, Élie Fadel, Peter Dorfmuller, Thierry Le Chevalier. Pathol Res Pract 2017
15
26

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view.
Glen Le Flahec, Briac Guibourg, Pascale Marcorelles, Arnaud Uguen. J Clin Pathol 2017
8
50


Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates.
Dario de Biase, Caterina de Luca, Gianluca Gragnano, Michela Visani, Claudio Bellevicine, Umberto Malapelle, Giovanni Tallini, Giancarlo Troncone. J Clin Pathol 2016
26
15

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients.
Elodie Long-Mira, Marius Ilie, Emmanuel Chamorey, Florence Leduff-Blanc, Henri Montaudié, Virginie Tanga, Maryline Allégra, Virginie Lespinet-Fabre, Olivier Bordone, Christelle Bonnetaud,[...]. Oncotarget 2018
24
16


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
9

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
S Hirota, K Isozaki, Y Moriyama, K Hashimoto, T Nishida, S Ishiguro, K Kawano, M Hanada, A Kurata, M Takeda,[...]. Science 1998
9

Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.
Muhammad Ahmed Farooq Anwar, Fadi Murad, Erin Dawson, Zakaria Y Abd Elmageed, Koji Tsumagari, Emad Kandil. J Surg Res 2016
30
10

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Keith T Flaherty, Jeffery R Infante, Adil Daud, Rene Gonzalez, Richard F Kefford, Jeffrey Sosman, Omid Hamid, Lynn Schuchter, Jonathan Cebon, Nageatte Ibrahim,[...]. N Engl J Med 2012
9

Improved survival with MEK inhibition in BRAF-mutated melanoma.
Keith T Flaherty, Caroline Robert, Peter Hersey, Paul Nathan, Claus Garbe, Mohammed Milhem, Lev V Demidov, Jessica C Hassel, Piotr Rutkowski, Peter Mohr,[...]. N Engl J Med 2012
9

Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France).
E Long, M Ilie, S Lassalle, C Butori, G Poissonnet, K Washetine, J Mouroux, V Lespinet, J P Lacour, V Taly,[...]. J Eur Acad Dermatol Venereol 2015
13
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.